FCX
45
-2
JNJ
36
6
LEN
38
-3
STT
50
-7
PPG
58
-2
CMI
52
-3
PWR
67
-3
MCD
55
-4
COF
50
-3
CFG
42
-4
GOOG
81
-8
PBI
58
-8
KO
46
2
CRM
67
-7
BK
66
-2
OMC
37
-2
URBN
68
-2
IVZ
48
-5
MAS
48
-3
FSLR
49
3
FCX
45
-2
JNJ
36
6
LEN
38
-3
STT
50
-7
PPG
58
-2
CMI
52
-3
PWR
67
-3
MCD
55
-4
COF
50
-3
CFG
42
-4
GOOG
81
-8
PBI
58
-8
KO
46
2
CRM
67
-7
BK
66
-2
OMC
37
-2
URBN
68
-2
IVZ
48
-5
MAS
48
-3
FSLR
49
3
Financhill
Back

Equity Residential Vs. Monopar Therapeutics Industry Stock Comparison

Sell
34

EQR
Equity Residential

Last Price:
70.94
Seasonality Move:
0.91%
Buy
75

MNPR
Monopar Therapeutics

Last Price:
30.15
Seasonality Move:
35.55%
Sell
34
Equity Residential (EQR) is a Sell

Is Equity Residential a Buy, Sell or Hold?

  • The current Equity Residential [EQR] share price is $72.77. The Score for EQR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • EQR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Monopar Therapeutics (MNPR) is a Buy

Is Monopar Therapeutics a Buy, Sell or Hold?

  • The current Monopar Therapeutics [MNPR] share price is $30.68. The Score for MNPR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • MNPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EQR Stock Price Chart

What is Equity Residential's stock price today?

  • The Equity Residential share price today is $72.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EQR is experiencing selling pressure, which indicates risk of future bearish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics's stock price today?

  • The Monopar Therapeutics share price today is $30.68
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.

EQR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 43.19 Sell
Chaikin Money Flow: -1387630 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.98 - 75.7) Sell
Bollinger Bands (100): (71.56 - 75.8) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.92 Buy
Relative Strength Index (14 RSI): 76.63 Buy
Chaikin Money Flow: 62338 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.5 - 24.7) Buy
Bollinger Bands (100): (1.59 - 18.41) Buy

EQR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 73.3 Sell
20-day SMA: 74.49 Sell
50-day SMA: 73.8 Sell
200-day SMA: 69.48 Buy
8-day EMA: 73.41 Sell
20-day EMA: 73.86 Sell
50-day EMA: 73.85 Sell
200-day EMA: 70.26 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.74 Buy
20-day SMA: 22.43 Buy
50-day SMA: 16.57 Buy
200-day SMA: 6.79 Buy
8-day EMA: 25.62 Buy
20-day EMA: 22.75 Buy
50-day EMA: 17.67 Buy
200-day EMA: 9.07 Buy

Equity Residential Earnings Growth & EQR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.15 per share, and an increase next year of $0.21 per share.

Monopar Therapeutics Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.58 per share, and a decrease next year of $0.91 per share.

Equity Residential Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):